Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti ‐viral therapy in patients with chronic hepatitis B

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - October 11, 2018 Category: Drugs & Pharmacology Authors: Yao ‐Chun Hsu, Tomi Jun, Yen‐Tsung Huang, Ming‐Lun Yeh, Chia‐Long Lee, Shintaro Ogawa, Shu‐Hsien Cho, Jaw‐Town Lin, Ming‐Lung Yu, Mindie H. Nguyen, Yasuhito Tanaka Source Type: research